Jerome D. Goldberg

Array ( [id] => 2587742 [patent_doc_number] => 04963577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-10-16 [patent_title] => 'Use of the thiazole derivative tiprotimod for the preparation of an agent for the therapy of virus infections' [patent_app_type] => 1 [patent_app_number] => 7/350957 [patent_app_country] => US [patent_app_date] => 1989-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1150 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/963/04963577.pdf [firstpage_image] =>[orig_patent_app_number] => 350957 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2682439 [patent_doc_number] => 05045543 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-03 [patent_title] => '5-amino or substituted amino 1,2,3-triazoles useful as antimetastatic agents' [patent_app_type] => 1 [patent_app_number] => 7/348823 [patent_app_country] => US [patent_app_date] => 1989-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6197 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/045/05045543.pdf [firstpage_image] =>[orig_patent_app_number] => 348823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2695018 [patent_doc_number] => 05019596 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-28 [patent_title] => 'Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic acid' [patent_app_type] => 1 [patent_app_number] => 7/348171 [patent_app_country] => US [patent_app_date] => 1989-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3403 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/019/05019596.pdf [firstpage_image] =>[orig_patent_app_number] => 348171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2740802 [patent_doc_number] => 05002755 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-26 [patent_title] => 'Method of controlling nephrotoxicity of anti-tumor plaintum compounds' [patent_app_type] => 1 [patent_app_number] => 7/344487 [patent_app_country] => US [patent_app_date] => 1989-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4389 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/002/05002755.pdf [firstpage_image] =>[orig_patent_app_number] => 344487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2677903 [patent_doc_number] => 05004593 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-04-02 [patent_title] => 'Hexamethylmelamine formulation exhibiting reduced neurotoxicity' [patent_app_type] => 1 [patent_app_number] => 7/339481 [patent_app_country] => US [patent_app_date] => 1989-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3897 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/004/05004593.pdf [firstpage_image] =>[orig_patent_app_number] => 339481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2637847 [patent_doc_number] => 04914131 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-04-03 [patent_title] => 'Antiviral pharmaceutical preparations and methods for their use' [patent_app_type] => 1 [patent_app_number] => 7/338448 [patent_app_country] => US [patent_app_date] => 1989-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 9 [patent_no_of_words] => 5247 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/914/04914131.pdf [firstpage_image] =>[orig_patent_app_number] => 338448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2967608 [patent_doc_number] => 05202320 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-04-13 [patent_title] => 'Method for treating leishmaniasis' [patent_app_type] => 1 [patent_app_number] => 7/334730 [patent_app_country] => US [patent_app_date] => 1989-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2257 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/202/05202320.pdf [firstpage_image] =>[orig_patent_app_number] => 334730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2733700 [patent_doc_number] => 05051416 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-24 [patent_title] => 'Oral antibacterial method' [patent_app_type] => 1 [patent_app_number] => 7/331853 [patent_app_country] => US [patent_app_date] => 1989-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1012 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/051/05051416.pdf [firstpage_image] =>[orig_patent_app_number] => 331853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2632942 [patent_doc_number] => 04957922 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1990-09-18 [patent_title] => 'Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3- carboxylic acid' [patent_app_type] => 1 [patent_app_number] => 7/329922 [patent_app_country] => US [patent_app_date] => 1989-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7598 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/04/957/04957922.pdf [firstpage_image] =>[orig_patent_app_number] => 329922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2684556 [patent_doc_number] => 05049396 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-09-17 [patent_title] => 'Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer sensitive to treatment' [patent_app_type] => 1 [patent_app_number] => 7/329379 [patent_app_country] => US [patent_app_date] => 1989-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3617 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/049/05049396.pdf [firstpage_image] =>[orig_patent_app_number] => 329379 [rel_patent_id] =>[rel_patent_doc_number] =>)